longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

FBRX

FBRX
----

LongbridgeAI

Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?

PR Newswire
Aug 6, 2026 at 07:48 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Halper Sadeh LLC is investigating MarketAxess, Sanara MedTech, Forte Biosciences, and Luxfer Holdings for potential breaches of fiduciary duties regarding their proposed sales. The firm alleges insiders may receive unfair benefits and transactions could limit competing offers. Shareholders are encouraged to contact the law firm to discuss legal rights and options on a contingent fee basis.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

MarketAxess Holdings Inc. ()'s sale to Intercontinental Exchange, Inc. for $167.00 per share in cash. If you are a MarketAxess shareholder, click here to learn more about your legal rights and options.

Sanara MedTech Inc. ()'s sale to MiMedx Group, Inc. for $33.00 in cash and 0.4735 shares of MiMedx common stock for each share of Sanara common stock. If you are a Sanara shareholder, click here to learn more about your legal rights and options.

Forte Biosciences, Inc. ()'s sale to argenx for $77.00 per share in cash. If you are a Forte shareholder, click here to learn more about your rights and options.

Luxfer Holdings PLC ()'s sale to affiliates of Wynnchurch Capital, L.P. for $17.37 per ordinary share in cash. If you are a Luxfer shareholder, click here to learn more about your legal rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Login to unlock1,718characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Forte Biosciences

Forte Biosciences

USFBRX

0.00%

Sanara Medtech

Sanara Medtech

USSMTI

-0.31%

MarketAxess

MarketAxess

USMKTX

-0.06%